BT-001, AN ONCOLYTIC VACCINIA VIRUS ARMED WITH A TREG-DEPLETING HUMAN RECOMBINANT ANTI-CTLA4 ANTIBODY AND GM-CSF TO TARGET THE TUMOR MICROENVIRONMENT-MedSci.cn

BT-001, AN ONCOLYTIC VACCINIA VIRUS ARMED WITH A TREG-DEPLETING HUMAN RECOMBINANT ANTI-CTLA4 ANTIBODY AND GM-CSF TO TARGET THE TUMOR MICROENVIRONMENT

Semmrich, M; Marchand, JB; Fend, L; Rehn, M; Silvestre, N; Martensson, L; Foloppe, J; Teige, I; Quemeneur, E; Frendeus, B

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (): A356

科室
- - 订阅+
  - 更多科室
工具
服务